Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H1N1 Monovalent Subunit Vaccine Dose-Ranging Study
NCT00971906Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2009
- Primary completion
- Oct 2009
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 3
01
Overview
A Phase 3 trial of Influenza A (H1N1) vaccine in influenza A H1N1 infection (H1N1), sponsored by Novartis. Started Aug 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT00971906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00971906.